QALVORA
LIVE

Serial Number

98964011

Owner

Wang Qi Ying

Attorney

Marek Krizka

First Use Date

Oct 9, 2025

Filing Date

Jan 15, 2025

Add to watchlist:

No watchlists yet
View on USPTO

QALVORA Trademark

Serial Number: 98964011 • Registration: 8328135

QALVORA is a trademark filed by Wang Qi Ying on January 15, 2025. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Wang Qi Ying

No. 3, Xinjie Street, Bantian, Longgang
Shenzhen 518100 , CN

Entity Type: 16

Trademark Details

Filing Date

January 15, 2025

Registration Date

June 30, 2026

First Use Anywhere

October 9, 2025

First Use in Commerce

October 10, 2025

Published for Opposition

September 9, 2025

Goods & Services

Devices for measuring blood sugar for medical purposes; Devices for monitoring blood glucose for medical purposes; Medical devices and apparatus, namely, medical guidewires and parts and fittings therefor; Medical devices and apparatus, namely, mesh graft made primarily of artificial materials for pelvic floor reconstruction; Medical devices and apparatus, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; Medical devices and apparatus, namely, vacuum assisted breast biopsy system and parts and fittings therefor; Medical devices for closing wounds; Medical devices for monitoring blood oxygen saturation, blood gas concentrations and vital signs; Medical devices for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events; Medical devices for monitoring blood properties and respiratory events; Medical devices for monitoring vital signs, blood properties and respiratory events; Medical devices for moxibustion therapy; Medical devices for nonsurgical cosmetic treatments; Medical devices for obtaining body fluid samples; Medical devices for placing and securing catheters; Medical devices for treating congestive heart failure; Medical devices for treating sleep disorders; Medical devices for treating vascular bifurcations; Medical devices for use in cannulation or to stem the flow of traumatic bleeding, namely, tourniquets; Medical devices to treat intravascular sites; Medical devices used in colostomy procedures to collect waste materials; Medical devices, namely, devices for measuring wounds; Medical devices, namely, hand-held motorized, vibrating devices used near injection sites for reducing pain during hypodermic needle injections; Medical devices, namely, minimally invasive devices for abdominal aortic aneurysms repair; Medical devices, namely, minimally invasive neurovascular devices for the treatment of neurological conditions; Medical devices, namely, myocardial ischemia scanning devices; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Medical apparatus, namely, bi-level positive airway pressure (BPAP) devices; Medical apparatus, namely, continuous positive airway pressure (CPAP) devices; Medical apparatus, namely, electric heating devices for curative treatment; Medical apparatus, namely, infusion and injection devices for administering drugs; Medical apparatus, namely, non- or low-compression devices for holding thermal packs to the breasts; Medical apparatus, namely, therapeutic devices for delivering specifically engineered pressure and gas mixtures for medical benefit; Medical apparatus, namely, tick removal devices; Medical apparatus, namely, timing devices for uterine contractions; Medical apparatus, namely, variable positive airway pressure devices (VPAP); Medical cutting devices; Medical hearing instruments and parts of such devices; Medical lancing devices; Medical testing devices for measuring hearing loss in patients, namely, audiometers; Attachments for medical injection devices to aid in controlling the depth of the injections; Attachments for medical injection devices to aid in holding injection needles perpendicular to the skin; Attachments for medical injection devices to aid in stabilizing flow during injection of pharmaceuticals; Blood pressure and diabetic diagnostic medical devices; Clothing extension support devices for use during pregnancy for medical purposes; Coatings sold as an integral component of medical stents and other implantable medical devices; Disposable medical devices for treating constipation; Light emitting diode (LED) devices for energy-efficient replacement of standard tungsten-filament lighting incorporated into hand-held medical instruments; Mountable medical devices that hold pre-folded military tourniquets for rapid acquisition and deployment thereof; Non-invasive medical devices for use in treating urinary incontinence; Portable medical devices used for breathing exercises, namely, portable devices used for endogenous breathing exercises and for respiratory muscle training; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; Saliva collection devices for medical purposes; Surgical and medical implant devices composed of artificial materials, namely, vertebral staple-shaped implants; Telemetry devices for medical applications

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 30, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 30, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 10, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 10, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 5, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 21, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 21, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2026 CRFA
ASSIGNED TO LIE
May 21, 2026 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 11, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
May 11, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Apr 24, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 24, 2026 AITU
USE AMENDMENT FILED
Nov 30, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 30, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 8, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 20, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 2, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 2, 2025 GNRT
NON-FINAL ACTION WRITTEN
Jul 2, 2025 CNRT
ASSIGNED TO EXAMINER
Jun 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2025 NWOS
NEW APPLICATION ENTERED
Jan 15, 2025 NWAP